These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 14599854

  • 61.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 62. Induction therapy with daclizumab as part of the immunosuppressive regimen in human small bowel and multiorgan transplants.
    Carreño MR, Kato T, Weppler D, Mathew JM, Fuller L, Gomez C, Salman F, Garcia-Morales R, Ciancio G, Burke GW, Esquenazi V, Miller J, Tzakis AG.
    Transplant Proc; 2001; 33(1-2):1015-7. PubMed ID: 11267170
    [No Abstract] [Full Text] [Related]

  • 63. Clinical advances in therapies targeting the interleukin-2 receptor.
    Church AC.
    QJM; 2003 Feb; 96(2):91-102. PubMed ID: 12589007
    [No Abstract] [Full Text] [Related]

  • 64.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 65. Anti-interleukin-2 receptor therapy in combination with mycophenolate mofetil is associated with more severe hepatitis C recurrence after liver transplantation.
    Nelson DR, Soldevila-Pico C, Reed A, Abdelmalek MF, Hemming AW, Van der Werf WJ, Howard R, Davis GL.
    Liver Transpl; 2001 Dec; 7(12):1064-70. PubMed ID: 11753908
    [Abstract] [Full Text] [Related]

  • 66.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 67.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 68. Two doses of daclizumab are sufficient for prolonged interleukin-2Ralpha chain blockade.
    ter Meulen CG, Baan CC, Hené RJ, Hilbrands LB, Hoitsma AJ.
    Transplantation; 2001 Nov 27; 72(10):1709-10. PubMed ID: 11726840
    [No Abstract] [Full Text] [Related]

  • 69. Steroid elimination 24 hours after liver transplantation using daclizumab, tacrolimus, and mycophenolate mofetil.
    Washburn K, Speeg KV, Esterl R, Cigarroa F, Pollack M, Tourtellot C, Maxwell P, Halff G.
    Transplantation; 2001 Nov 27; 72(10):1675-9. PubMed ID: 11726831
    [Abstract] [Full Text] [Related]

  • 70.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 71.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 72.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 73.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 74.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 75.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 76.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 77.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 78.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 79. Immunosuppressive therapy for ocular diseases.
    Jap A, Chee SP.
    Curr Opin Ophthalmol; 2008 Nov 27; 19(6):535-40. PubMed ID: 18854699
    [Abstract] [Full Text] [Related]

  • 80. Anti-interleukin 2-receptor antibodies: a comparative study with polyclonal antibodies in kidney transplantation: preliminary results.
    Martins L, Henriques AC, Dias L, Sarmento AM, Pereira MC, Guimarães S.
    Transplant Proc; 2000 Dec 27; 32(8):2623-5. PubMed ID: 11134730
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.